🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Threonine is an essential amino acid and must be obtained from the diet. Th...
Status
Recruiting
Location
The Hospital for Sick Children
Start Date
2024-02-03
Trial ID
NCT06225648
Treatments Being Tested
The study is a Phase 1b/2, multi-center, open-label, dose escalation trial ...
Status
Recruiting
Location
START Los Angeles
Start Date
2026-04-22
Trial ID
NCT07558733
Treatments Being Tested
The purpose of this study is to see if the study drug, called Vactosertib, ...
Status
Completed
Location
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2017-07-21
Trial ID
NCT03143985
Treatments Being Tested
The objective of this clinical trial is to evaluate, in clinically healthy ...
Status
Completed
Location
Health School-Polytechnic Institute of Coimbra
Start Date
2023-02-02
Trial ID
NCT07205237
Treatments Being Tested
The primary purpose of this study is to determine the safety and tolerabili...
Status
Terminated
Location
Mount Sinai Comprehensive Cancer Center
Start Date
2023-03-03
Trial ID
NCT05469178
Treatments Being Tested
The majority of patients (pts) with breast cancer have hormone receptor pos...
Status
Active Not Recruiting
Location
University of Miami
Start Date
2023-06-12
Trial ID
NCT05826964
The purpose of this study is to test the safety of an investigational drug ...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2021-04-16
Trial ID
NCT04730258
Treatments Being Tested
This phase 2 trial is a single-site sequential, multiple assignment, random...
Status
Recruiting
Location
Corewell Health West
Start Date
2026-06
Trial ID
NCT07459504
Treatments Being Tested
A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in partici...
Status
Recruiting
Location
Precision Next Gen Oncology & Research Center
Start Date
2023-11-09
Trial ID
NCT06075810
Treatments Being Tested
This trial explores the immunologic effects of vemurafenib (BRAF inhibitor)...
Status
Withdrawn
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2015-08
Trial ID
NCT02427893
Treatments Being Tested